ACP calls for increased oversight and regulation of PBMs, including gag clause ban
The American College of Physicians (ACP) says its time to improve transparency and take a closer look at the role of pharmacy benefit managers in order to stem the high cost of prescription drugs.
The ACP, the country’s largest medical specialty organization which represents internists, also called for addressing issues in Medicare and Medicaid in two new policy papers on mitigating rising prescription costs published today in the Annals of Internal Medicine. It made policy recommendations in a paper on public health plans and in a paper on pharmacy benefit managers (PBMs).
